Holen Sie sich die Stockscreener-App
1.61
0.31%
0.005
Schlusskurs vom Vortag:
$1.605
Offen:
$1.6
24-Stunden-Volumen:
86,560
Relative Volume:
0.40
Marktkapitalisierung:
$86.48M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-31.39M
KGV:
-1.9167
EPS:
-0.84
Netto-Cashflow:
$-18.45M
1W Leistung:
+0.63%
1M Leistung:
-4.73%
6M Leistung:
+4.55%
1J Leistung:
+131.22%
1-Tages-Spanne:
$1.57
$1.6298
1-Wochen-Bereich:
$1.54
$1.65
52-Wochen-Spanne:
$0.675
$2.45
Quince Therapeutics Inc Stock (QNCX) Company Profile
Firmenname
Quince Therapeutics Inc
Sektor
Branche
Telefon
415-910-5717
Adresse
611 GATEWAY BLVD., SUITE 273, SOUTH SAN FRANCISCO
Vergleichen Sie QNCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
QNCX
Quince Therapeutics Inc
|
1.61 | 86.21M | 0 | -31.39M | -18.45M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.12 | 101.77B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
573.38 | 60.12B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
452.00 | 59.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
750.78 | 44.90B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
341.80 | 35.07B | 3.81B | -644.79M | -669.77M | -6.24 |
Quince Therapeutics Inc Stock (QNCX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-08-05 | Eingeleitet | Citizens JMP | Mkt Outperform |
| 2025-03-24 | Eingeleitet | Oppenheimer | Outperform |
Quince Therapeutics Inc Aktie (QNCX) Neueste Nachrichten
How to interpret RSI for Quince Therapeutics Inc. stockJuly 2025 Reactions & AI Powered Market Entry Ideas - Newser
Quince Therapeutics Inc.’s volatility index tracking explainedMarket Volume Summary & Stock Portfolio Risk Management - Newser
Is Quince Therapeutics Inc. stock poised for growthJuly 2025 Technicals & Real-Time Volume Analysis Alerts - Newser
Will Quince Therapeutics Inc. Reverse From Oversold ConditionsJuly 2025 Action & Reliable Trade Execution Plans - beatles.ru
What is the earnings history of Quince Therapeutics Inc.July 2025 Market Mood & Free Verified High Yield Trade Plans - خودرو بانک
Intraday pattern recognizer results for Quince Therapeutics Inc.Weekly Loss Report & Daily Chart Pattern Signal Reports - Newser
Is Quince Therapeutics Inc. stock bottoming out2025 Sector Review & Low Risk High Win Rate Picks - Newser
Quince Therapeutics Inc. stock prediction for this weekEarnings Overview Summary & AI Driven Stock Movement Reports - Newser
Can Quince Therapeutics Inc. continue delivering strong returns2025 Pullback Review & Smart Investment Allocation Insights - 시사인 투데이
Published on: 2025-09-05 06:25:23 - Newser
What’s the outlook for Quince Therapeutics Inc.’s sectorQuarterly Investment Review & Growth-Oriented Investment Plans - خودرو بانک
Technical analysis overview for Quince Therapeutics Inc. stock2025 Big Picture & Growth Oriented Trade Recommendations - Newser
Using RSI to spot recovery in Quince Therapeutics Inc.Weekly Market Summary & Stock Market Timing Techniques - Newser
New Product Launches: Will They Boost Quince Therapeutics Inc. Stock in 20252025 Analyst Calls & Daily Profit Maximizing Trade Tips - Newser
Analyzing drawdowns of Quince Therapeutics Inc. with statistical toolsJuly 2025 Breakouts & Detailed Earnings Play Strategies - Newser
Quince Therapeutics Inc. stock momentum explainedBond Market & Real-Time Stock Movement Alerts - Newser
Real time social sentiment graph for Quince Therapeutics Inc.Recession Risk & Real-Time Market Trend Scan - Newser
Applying big data sentiment scoring on Quince Therapeutics Inc.2025 Big Picture & Safe Entry Zone Identification - Newser
Analyzing Quince Therapeutics Inc. with multi timeframe chartsTrade Exit Report & Safe Capital Growth Tips - Newser
Momentum divergence signals in Quince Therapeutics Inc. chartQuarterly Profit Review & Target Return Focused Stock Picks - Newser
Quince Therapeutics shares fall 1.56% intraday as CEO to present at H.C. Wainwright conference. - AInvest
Is now a turning point for Quince Therapeutics Inc.July 2025 Volume & Daily Stock Trend Watchlist - Newser
Published on: 2025-09-03 04:49:09 - Newser
Published on: 2025-09-03 04:36:47 - Newser
Is it time to cut losses on Quince Therapeutics Inc.Weekly Gains Summary & High Conviction Buy Zone Picks - Newser
How high can Quince Therapeutics Inc. stock goMarket Activity Report & Technical Pattern Based Signals - Newser
Ranking Quince Therapeutics Inc. among high performing stocks via toolsMarket Activity Summary & Capital Protection Trade Alerts - Newser
Is Quince Therapeutics Inc. a strong candidate for buy and holdJuly 2025 Macro Moves & Weekly High Potential Stock Alerts - خودرو بانک
Using data filters to optimize entry into Quince Therapeutics Inc.2025 Earnings Impact & Precise Swing Trade Alerts - Newser
How moving averages guide Quince Therapeutics Inc. tradingJuly 2025 Analyst Calls & Short-Term High Return Ideas - Newser
Candlestick signals on Quince Therapeutics Inc. stock todayJuly 2025 Snapshot & Reliable Intraday Trade Alerts - Newser
Quince Therapeutics to Present at H.C. Wainwright 27th Annual Global Investment Conference - BioSpace
Quince Therapeutics’ Strategic Momentum in Rare Disease Innovation - AInvest
Can machine learning forecast Quince Therapeutics Inc. recoveryJuly 2025 Opening Moves & Pattern Based Trade Signal System - Newser
Aug Outlook: Does Quince Therapeutics Inc. align with a passive investing strategyJuly 2025 Technicals & Free Weekly Chart Analysis and Trade Guides - خودرو بانک
Will Quince Therapeutics Inc. Benefit From Sector TailwindsJuly 2025 Intraday Action & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Technical Charts Suggest Momentum Shift in Quince Therapeutics Inc. getLinesFromResByArray error: size == 0 - thegnnews.com
Smart tools for monitoring Quince Therapeutics Inc.’s price actionJuly 2025 PreEarnings & Real-Time Buy Zone Alerts - Newser
Should you hold or exit Quince Therapeutics Inc. nowInflation Watch & Risk Controlled Stock Pick Alerts - Newser
Finanzdaten der Quince Therapeutics Inc-Aktie (QNCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):